This federal contract award, valued at $87,851.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PREZCOBIX 800 MG-150 MG tablets, a specialty medication, with a period of performance through January 20, 2023.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.